title: Ocular therapeutics.
authors.forename: Julie
authors.initials: J
authors.lastname: Albietz
authors.forename: Ian
authors.initials: I
authors.lastname: Douglas
authors.forename: Genevieve
authors.initials: G
authors.lastname: Napper
mesh_terms: D000257:Adenoviridae Infections / Q000175:diagnosis; D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D017321:Clinical Trials, Phase I as Topic; D003231:Conjunctivitis / Q000382:microbiology / Q000821:virology; D003320:Corneal Ulcer / Q000188:drug therapy; D003907:Dexamethasone / Q000627:therapeutic use; D003941:Diagnostic Techniques, Ophthalmological; D004338:Drug Combinations; D016503:Drug Delivery Systems; D005128:Eye Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010672:Phenytoin / Q000008:administration & dosage / Q000627:therapeutic use; D012590:Sclera; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D010672:Phenytoin; D003907:Dexamethasone; D017963:Azithromycin